|
|
||||||||
Departments of 1 Clinical Physiology and 2 Cardiology, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden; and 3 National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892
There are
experimental data suggesting that epinephrine (Epi) may act as a
cotransmitter in sympathetic nerves, stimulating presynaptic
2-receptors and enhancing
norepinephrine (NE) release. To examine neuronal Epi release, patients
with congestive heart failure and hypertension and healthy subjects
were examined with the isotope-dilution method. At baseline, small
cardiac and renal Epi spillovers were found in patients. During intense
supine exercise, cardiac NE and Epi spillovers increased concomitantly
with similar magnitude, whereas no renal Epi spillover could be
detected. Blockade of neuronal uptake 1 caused a consistent decrease in
both cardiac and renal fractional extractions of NE and Epi. The
present study demonstrates baseline cardiorenal Epi release in patients
with congestive heart failure and renal Epi release in hypertensive patients. Furthermore, Epi is removed by neuronal uptake in both the
heart and kidney, and cardiac Epi spillover increases during exercise.
This study, in contrast to other results, provides evidence for cardiac
neuronal Epi release.
neuronal epinephrine release
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |